# Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid

> **NCT04777604** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **OTHER:** Organoid

## Key facts

- **NCT ID:** NCT04777604
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2025-01-07
- **Final completion:** 2026-01-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04777604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04777604, "Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04777604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*